Local Chorus
Local news from local sources, read in your language.
Developing
Verified

China: Domestic drugs make up 80% of innovative drugs approved in first three quarters

🇨🇳 China 19:05 Health Business Tech Official2 updated 3 h ago first reported by 新华社

In short

Wang Weiming (王卫明), chief engineer of the Ministry of Industry and Information Technology, said on 20 October that domestic products account for 80% of the innovative drugs approved in China in the first three quarters of 2026. He spoke at a press conference held by the State Council Information Office.

Read the full story 1 min read

Domestic products make up 80% of the innovative drugs approved in China in the first three quarters of this year, according to Wang Weiming (王卫明), chief engineer of the Ministry of Industry and Information Technology. China News Service reported that he made the statement at a press conference held on 20 October by the State Council Information Office (国新办). [ 1 , 2 , 4 ]

China News Service said the press conference dealt with industrial and information-technology development in the first three quarters of 2026. Wang said drug research had achieved breakthroughs in several fields, naming oncology, psychiatry, anti-infection, gout and rare diseases. China News Service described them as major breakthroughs. [ 4 ]

36Kr (36氪) credited CCTV News for the report, and Jiemian (界面新闻) credited Xinhua. Xinhua published an item under the same headline. The documents do not give the number of drugs approved or a comparison with earlier periods. [ 1 , 2 , 3 ]

Why it matters

The figure comes from an official at a government press conference, and the documents give no further data or comparison. They show how officials describe progress in domestic drug development.

Key facts

  • Wang Weiming (王卫明), chief engineer of the Ministry of Industry and Information Technology, said domestic products make up 80% of innovative drugs approved in China in the first three quarters. [ 1 , 2 , 4 ]
  • He spoke at a press conference held by the State Council Information Office (国新办) on 20 October. [ 1 , 2 , 4 ]
  • The press conference covered industrial and information-technology development in the first three quarters of 2026. [ 4 ]
  • Wang said drug research had made breakthroughs in areas including oncology, psychiatry, anti-infection, gout and rare diseases. [ 1 , 2 , 4 ]

Confirmed by several sources

  • The ministry's chief engineer said 80% of the innovative drugs approved in China in the first three quarters were domestic. [ 1 , 2 , 3 , 4 ]
  • Wang Weiming named oncology, psychiatry, anti-infection, gout and rare diseases among the areas of drug research with breakthroughs. [ 1 , 2 , 4 ]

Still unclear

  • The number of innovative drugs approved and the figures behind the 80% share The documents give only the percentage, not the total number of approvals or a comparison with earlier periods.
  • Which drugs achieved the breakthroughs The documents list therapeutic areas but no specific drugs or approvals.

What local media are saying

Technology media36Kr carried the 80% figure and the list of therapeutic areas in a short item, crediting CCTV News. [ 1 ]
Business mediaJiemian carried the same statement in a short item, crediting Xinhua. [ 2 ]
Official sourcesXinhua ran the statement as a headline. China News Service described the press conference on first-three-quarters industrial and IT development and said Wang reported major breakthroughs in drug research. [ 3 , 4 ]

Timeline, local time

  1. 36Kr published the item on the 80% share. [ 1 ]
  2. Jiemian published the item. [ 2 ]
  3. Xinhua published the item. [ 3 ]
  4. China News Service published its report on the press conference. [ 4 ]